Alliance Global Partners Comments on Organigram Q1 Earnings

Organigram Holdings Inc. (TSE:OGI) – Research analysts at Alliance Global Partners cut their Q1 2025 earnings estimates for shares of Organigram in a note issued to investors on Wednesday, December 18th. Alliance Global Partners analyst A. Grey now anticipates that the company will earn ($0.05) per share for the quarter, down from their prior estimate of ($0.02). The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Alliance Global Partners also issued estimates for Organigram’s Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.04) EPS, Q4 2025 earnings at ($0.04) EPS, FY2025 earnings at ($0.16) EPS and FY2026 earnings at ($0.11) EPS.

Several other brokerages have also recently issued reports on OGI. Canaccord Genuity Group lowered their price target on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a research report on Monday, December 9th. ATB Capital decreased their target price on Organigram from C$5.25 to C$3.50 in a research note on Tuesday, December 17th.

Organigram Price Performance

TSE OGI opened at C$2.25 on Monday. The firm has a market capitalization of C$244.28 million, a PE ratio of -0.90, a P/E/G ratio of 0.42 and a beta of 1.13. The company has a debt-to-equity ratio of 1.13, a current ratio of 6.95 and a quick ratio of 2.62. Organigram has a 12 month low of C$1.67 and a 12 month high of C$3.95. The company’s 50 day simple moving average is C$2.26 and its 200 day simple moving average is C$2.30.

Insiders Place Their Bets

In other news, Senior Officer Paolo De Luca sold 12,014 shares of the company’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total transaction of C$30,275.28. 31.32% of the stock is currently owned by company insiders.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.